WNE Launches New Master’s Degree in Biopharmaceutical Technology

SPRINGFIELD — Western New England University (WNE) is launching a new master of science in biopharmaceutical technology (MSBT) program this fall. This innovative program is designed to meet the evolving needs of the biopharmaceutical industry and align with the Pharma 4.0 movement, which leverages digitalization to enhance therapeutic development and manufacturing.

The MSBT program offers an interdisciplinary curriculum blending pharmaceutical sciences, biopharmaceutics, and engineering. Students will train in state-of-the-art labs and gain hands-on experience in developing advanced therapeutic medicinal products (ATMPs), including cell and gene therapies and regenerative medicines. The program can be completed in as little as one year, providing a fast track to careers in biotech and biomanufacturing.

“This program reflects our commitment to preparing students both for the future of work and for the future of healthcare,” University President Robert Johnson said. “It addresses the growing workforce demands in biotech while equipping graduates with the skills needed to lead in an evolving industry.”

The curriculum emphasizes digital literacy, automation, and data fluency — skills essential for navigating Pharma 4.0, as outlined by the International Society for Pharmaceutical Engineering.

Supported by a $500,000 grant from the Healey-Driscoll administration through the Massachusetts Life Sciences Center, the MSBT program exemplifies WNE’s investment in workforce development and innovation. To learn more or apply, visit www.wne.edu/phs.